Cargando…
CD154 blockade modulates the ratio of Treg to Th1 cells and prolongs the survival of allogeneic corneal grafts in mice
Administration of anti-CD154 monoclonal antibody (mAb) may prolong the survival of an allograft; however, the associated therapeutic mechanisms remain poorly understood. This study aimed to evaluate the effects of anti-CD154 mAb on T-cell responses in a mouse model of corneal allograft transplantati...
Autores principales: | TAN, XIAOBO, ZENG, HUI, JIE, YING, ZHANG, YINGNAN, XU, QING, PAN, ZHIQIANG |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
D.A. Spandidos
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3961129/ https://www.ncbi.nlm.nih.gov/pubmed/24660031 http://dx.doi.org/10.3892/etm.2014.1527 |
Ejemplares similares
-
The Balance of Th1/Th2 and LAP+Tregs/Th17 Cells Is Crucial for Graft Survival in Allogeneic Corneal Transplantation
por: Li, Shang, et al.
Publicado: (2018) -
CD8+CD122+PD-1+ Tregs Synergize With Costimulatory Blockade of CD40/CD154, but Not B7/CD28, to Prolong Murine Allograft Survival
por: Liu, Huazhen, et al.
Publicado: (2019) -
All-trans retinoid acid promotes allogeneic corneal graft survival in mice by regulating Treg-Th17 balance in the presence of TGF-β
por: Wang, Xin, et al.
Publicado: (2015) -
Treg suppression of immunity within inflamed allogeneic grafts
por: Dai, Hehua, et al.
Publicado: (2022) -
IL-15 prolongs CD154 expression on human CD4 T cells via STAT5 binding to the CD154 transcriptional promoter
por: Lowe, RM, et al.
Publicado: (2014)